The News Review:
- ‘Green chemistry’ movement sprouts in colleges companies
- Reel Review: Undeniable chemistry makes ‘Duplicity’ crackle
- BioRelix and Dalton Medicinal Chemistry Expand and Renew Research …
‘Green chemistry’ movement sprouts in colleges companies
New York Times
“Industry really sees the value of ‘green chemistry’” said Julie Haack assistant head of the University of regon’s chemistry department. “If you want to recruit the best chemists wouldn’t it make sense to promote the opportunity to work in an environment where they can align their interest in the environment with their passion which is chemistry?”Having employees concerned about sustainability leads to more innovative long-term solutions said Neil Hawkins vice president for sustainability at Dow Chemical Co. “It’s very important to us to have a pipeline of the best and the brightest students in science and technology but that also have a broader perspective as well so they can understand the tradeoffs” Hawkins said. “This means balancing environmental social and economic decisions. “Many universities are responding by creating a green-chemistry curriculum.
Reel Review: Undeniable chemistry makes ‘Duplicity’ crackle
La Jolla Light
But I have feeling that the crackling on-screen chemistry between Julia Roberts and Clive wen would burst off the screen with a plot line about watching paint dry – just like it does in “Duplicity. The plot is complex and keeps you on your toes (and sometimes completely confused) with countless twists and turns that feel more like inspired dancing than cheap plot devices. Even with some unnecessary and sometimes repetitive scenes that prolong the film a bit more than necessary the sparks that fly between Roberts and wen are enough to keep you thoroughly interested. But if it were anyone else paired up on that screen “Duplicity” could have been a self-indulgent disaster though with some welcome relief from outstanding supporting cast members Paul Giamiatti and Tom Wilkinson as rival chief executives.
BioRelix and Dalton Medicinal Chemistry Expand and Renew Research …
FXBusiness
Dalton Medicinal Chemistry will apply their proprietary insights to the design and synthesis of new classes of compounds against selected Riboswitch targets. BioRelix will advance these compounds with their cutting edge array of biological assays and thorough knowledge of Riboswitch drug discovery and development. Brian Dixon BioRelix CE commented “We are pleased to have the opportunity to expand and renew our productive relationship with the creative team at Dalton Medicinal Chemistry. We are confident their expertise insights and commitment to high quality medicinal chemistry coupled with our propriety and leading position on Riboswitches will continue to deliver value in important new medicines. Judd Berman Co-founder of Dalton Medicinal Chemistry said: “We are delighted to work further with BioRelix in the discovery and development of much needed new anti-infective agents.
Related from Cannabisfanclub: Court clarifies who can grow medicinal pot